BNY (Nominees) Limited (as nominee of The Bank of New York Mellon)
Foreign entityUnit number: 4008524626
2
Ownership
0
Board positions
0
Director positions
0
Other roles
48
People in network
People in network(48)
People who held roles at the same companies, or who co-own the same companies
Lars Holtug
ASCENDIS PHARMA A/S, Evaxion A/S
Michael Wolff Jensen
ASCENDIS PHARMA A/S, ASCENDIS PHARMA A/S
Jan Møller Mikkelsen
ASCENDIS PHARMA A/S, ASCENDIS PHARMA A/S
Ownership(2)
90-99,99%
Ownership
Active
90-99,99%
Ownership
Active
Indirect ownership(6)
Companies owned indirectly through ownership chains.
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
CVR: 32323502
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)
Ascendis Pharma Endocrinology Division A/S
CVR: 32323537
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)
ASCENDIS PHARMA BONE DISEASES A/S
CVR: 32323596
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)
Ascendis Pharma Growth Disorders A/S
CVR: 32323677
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)
Ascendis Pharma Oncology Division A/S
CVR: 41034076
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)
Ascendis Pharma Europe A/S
CVR: 44420449
90-99,99%
Effective ownership
Depth: 1
Ownership path:
ASCENDIS PHARMA A/S(90-99,99%)